AMY HANDLEY: Open Payments
NPI 1255760773 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 53 payments from 23 companies in 2025. Trend: 2023 $953 · 2024 $1,021 · 2025 $1,535
Food & beverage: $937Long term medical supply or device loan: $499Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $544 |
| ARRAY BIOPHARMA INC | 9 | $144 |
| Astellas Pharma US Inc | 1 | $100 |
| EMD Serono, Inc. | 3 | $89 |
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| Gilead Sciences, Inc. | 4 | $73 |
| Janssen Biotech, Inc. | 3 | $64 |
| Geron Corporation | 3 | $55 |
| PFIZER INC. | 2 | $41 |
| Rigel Pharmaceuticals, Inc. | 1 | $38 |
Products named: KISQALI, BRAFTOVI, XTANDI, RYTELO, Trodelvy, LORBRENA, SCEMBLIX, IMFINZI.
Industry payments across UT — which companies pay providers there.
